Integrated Investment Consultants LLC Acquires 10,800 Shares of Colgate-Palmolive Company $CL

Integrated Investment Consultants LLC raised its holdings in Colgate-Palmolive Company (NYSE:CL) by 264.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 14,890 shares of the company’s stock after purchasing an additional 10,800 shares during the quarter. Integrated Investment Consultants LLC’s holdings in Colgate-Palmolive were worth $1,177,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in CL. Brighton Jones LLC raised its position in shares of Colgate-Palmolive by 4.4% during the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after acquiring an additional 450 shares during the last quarter. Woodline Partners LP raised its position in shares of Colgate-Palmolive by 76.3% during the first quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock worth $4,344,000 after acquiring an additional 20,062 shares during the last quarter. Schnieders Capital Management LLC. raised its position in shares of Colgate-Palmolive by 2.0% during the second quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock worth $1,136,000 after acquiring an additional 245 shares during the last quarter. Nebula Research & Development LLC raised its position in shares of Colgate-Palmolive by 165.5% during the second quarter. Nebula Research & Development LLC now owns 10,326 shares of the company’s stock worth $939,000 after acquiring an additional 6,437 shares during the last quarter. Finally, Sei Investments Co. raised its position in shares of Colgate-Palmolive by 21.7% during the second quarter. Sei Investments Co. now owns 657,093 shares of the company’s stock worth $59,732,000 after acquiring an additional 116,968 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on CL shares. Rothschild & Co Redburn set a $100.00 target price on Colgate-Palmolive and gave the stock a “buy” rating in a research report on Tuesday, April 21st. Citigroup boosted their target price on Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Monday, February 2nd. Weiss Ratings upgraded Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, May 4th. TD Cowen restated a “hold” rating and set a $85.00 target price on shares of Colgate-Palmolive in a research report on Tuesday, March 31st. Finally, Morgan Stanley restated an “overweight” rating on shares of Colgate-Palmolive in a research report on Monday, May 4th. Twelve analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $95.88.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $88.20 on Monday. The firm has a market cap of $70.76 billion, a price-to-earnings ratio of 34.32, a price-to-earnings-growth ratio of 4.58 and a beta of 0.31. The stock’s 50-day moving average is $86.30 and its 200-day moving average is $84.73. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $99.33. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.02 and a quick ratio of 0.67.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, May 1st. The company reported $0.97 EPS for the quarter, beating analysts’ consensus estimates of $0.94 by $0.03. The company had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.22 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The company’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.91 earnings per share. Equities analysts predict that Colgate-Palmolive Company will post 3.82 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Monday, April 20th were issued a dividend of $0.53 per share. The ex-dividend date was Monday, April 20th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 annualized dividend and a yield of 2.4%. Colgate-Palmolive’s dividend payout ratio is currently 82.49%.

Trending Headlines about Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Shareholders backed the company’s board, executive pay practices, and auditor, signaling continued investor support for management and governance. Article Title
• Neutral Sentiment: Zacks Research slightly lowered its longer-term earnings outlook for Colgate-Palmolive, including FY2027 to $4.01 from $4.15 and FY2028 to $4.39 from $4.44, while keeping estimates near the broader consensus.
• Negative Sentiment: The firm also cut near-term estimates, including FY2026 to $3.80 from $3.89, Q2 2026 to $0.95 from $0.97, Q3 2026 to $0.91 from $0.96, and Q4 2026 to $0.96 from $1.00, raising concern about modest earnings headwinds.
• Negative Sentiment: Additional trims to 2027 and 2028 quarterly forecasts point to a softer earnings trajectory, which can weigh on sentiment for a stable consumer staples stock like Colgate-Palmolive.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.